The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118025386 11802538 6 F 2010 20160809 20151204 20160819 EXP GB-PFIZER INC-2015419094 PFIZER 71.00 YR F Y 0.00000 20160819 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118025386 11802538 1 PS AMLODIPINE BESILATE AMLODIPINE BESYLATE 1 Unknown UNK U 19787
118025386 11802538 2 SS HERCEPTIN TRASTUZUMAB 1 Subcutaneous 450 MG, UNK U B1010B08 0 450 MG
118025386 11802538 3 SS HERCEPTIN TRASTUZUMAB 1 Subcutaneous 450 MG, UNK U B00442B01 0 450 MG
118025386 11802538 4 SS HERCEPTIN TRASTUZUMAB 1 Subcutaneous 450 MG, UNK U B104B13 0 450 MG
118025386 11802538 5 SS HERCEPTIN TRASTUZUMAB 1 Subcutaneous 600 MG, UNK U B1010B08,B00442B01,B104B13 0 600 MG

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
118025386 11802538 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118025386 11802538 Arthralgia
118025386 11802538 Bladder irritation
118025386 11802538 Blood pressure increased
118025386 11802538 Dizziness
118025386 11802538 Dry skin
118025386 11802538 Dysuria
118025386 11802538 Fall
118025386 11802538 Fatigue
118025386 11802538 Feeling abnormal
118025386 11802538 Gingival pain
118025386 11802538 Head injury
118025386 11802538 Hepatic neoplasm
118025386 11802538 Joint swelling
118025386 11802538 Lacrimation increased
118025386 11802538 Local swelling
118025386 11802538 Musculoskeletal stiffness
118025386 11802538 Myalgia
118025386 11802538 Nasal congestion
118025386 11802538 Neoplasm progression
118025386 11802538 Neuralgia
118025386 11802538 Onychoclasis
118025386 11802538 Photophobia
118025386 11802538 Pruritus
118025386 11802538 Rhinorrhoea
118025386 11802538 Sinus pain
118025386 11802538 Skin abrasion
118025386 11802538 Tenderness
118025386 11802538 Trigeminal neuralgia
118025386 11802538 Urinary retention
118025386 11802538 Urine flow decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found